2010
DOI: 10.1189/jlb.0909635
|View full text |Cite
|
Sign up to set email alerts
|

Plasmacytoid dendritic cells in HIV infection: striking a delicate balance

Abstract: pDC are the most potent IFN-alpha-producing cells in the body and serve as a vital link between innate and adaptive immunity. Deficiencies in pDC function were among the earliest observations of immune dysfunction in HIV-1 infection. Herein, we review the status of pDC in individuals with HIV-1 infection and the potential role of these cells in pathogenesis. We begin by reviewing the basic properties of pDC and then discuss the compromise in circulating pDC numbers and function in early and viremic HIV-1 infec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
110
0
3

Year Published

2011
2011
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 118 publications
(117 citation statements)
references
References 152 publications
4
110
0
3
Order By: Relevance
“…TGF-␤ also inhibits IFN-I production by pDCs ex vivo (21) and the expression of costimulatory molecules major histocompatibility complex class II (MHC-II), CD40, and CD80/CD86 in bone marrow (BM)-derived DCs in vitro (22). Notably, DCs from mice infected with a persistent strain of LCMV, strain Cl13, have reduced maturation (23), and pDCs produce substantially reduced amounts of IFN-I compared with the amounts produced by pDCs from noninfected hosts (24), similar to the findings for pDCs from HIV-infected individuals (25). These studies raised the possibility that TGF-␤ signaling may limit DC maturation and/or cytokine production during in vivo viral infection, attenuating early viral containment and promoting viral persistence.…”
supporting
confidence: 59%
“…TGF-␤ also inhibits IFN-I production by pDCs ex vivo (21) and the expression of costimulatory molecules major histocompatibility complex class II (MHC-II), CD40, and CD80/CD86 in bone marrow (BM)-derived DCs in vitro (22). Notably, DCs from mice infected with a persistent strain of LCMV, strain Cl13, have reduced maturation (23), and pDCs produce substantially reduced amounts of IFN-I compared with the amounts produced by pDCs from noninfected hosts (24), similar to the findings for pDCs from HIV-infected individuals (25). These studies raised the possibility that TGF-␤ signaling may limit DC maturation and/or cytokine production during in vivo viral infection, attenuating early viral containment and promoting viral persistence.…”
supporting
confidence: 59%
“…Differentiation of DCs from hematopoietic progenitor cells (HPCs) is regulated by complex signaling pathways that involve soluble cytokines and transcription factors (TFs) in bone marrow (BM) and peripheral lymphoid tissues (3,4). Impaired DC differentiation facilitates the escape of tumor cells and invading pathogens from the host's immune surveillance (5)(6)(7). Although many molecular mechanisms linked to DC differentiation have been proposed, a complete picture has yet to be obtained (8)(9)(10).…”
mentioning
confidence: 99%
“…46 It is probable that a delicate balance exist in vivo between the beneficial effects of IFN␣ on controlling viral load and/or coinfections (HCV and others) and detrimental side effects on immune activation, depending of viral load itself and to multiple innate factors, including pDCs. 47,48 Altogether, we have shown here that HIV disease progression correlates with the occurrence of dysfunctional naive CD8 low T cells in the setting of chronic systemic immune activation. Although the origin and the fate of these cells remain to be determined, it is tempting to extrapolate that a functionally impaired naive CD8 low T-cell compartment in vivo may further cripple T-cell immune responses during the course of HIV disease progression.…”
Section: Discussionmentioning
confidence: 97%